Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex.

Abstract

Aripiprazole, a novel atypical antipsychotic drug, can significantly increase dopamine (DA) levels in the prefrontal cortex of rats, but only at low doses below 1mg/kg. The aim of the present work was to test the effect of aripiprazole (0, 0.1, 0.3, 3 and 30 mg/kg, i.p.) on extracellular levels of monoamines in the prefrontal cortex of freely moving C57BL… (More)

Topics

  • Presentations referencing similar topics